STAT3 and hepatocellular carcinoma: Deficiency of PTPN2 in hepatocytes resulted in maladjustment of signal transduction and activation of transcription 1 (STAT1) and STAT3, which eventually accelerated the progression on the spectrum of steatosis-NASH-cirrhosis-hepatocellular carcinoma (HCC) in mice.